- Home
- UXIN vs PRTA Comparison
UXIN vs PRTA Comparison
Compare UXIN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UXIN
- PRTA
- Stock Information
- Founded
- UXIN 2011
- PRTA 2012
- Country
- UXIN China
- PRTA Ireland
- Employees
- UXIN N/A
- PRTA N/A
- Industry
- UXIN Business Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- UXIN Consumer Discretionary
- PRTA Health Care
- Exchange
- UXIN Nasdaq
- PRTA Nasdaq
- Market Cap
- UXIN 940.1M
- PRTA 809.8M
- IPO Year
- UXIN 2018
- PRTA N/A
- Fundamental
- Price
- UXIN $3.72
- PRTA $6.18
- Analyst Decision
- UXIN
- PRTA Buy
- Analyst Count
- UXIN 0
- PRTA 9
- Target Price
- UXIN N/A
- PRTA $27.67
- AVG Volume (30 Days)
- UXIN 50.3K
- PRTA 1.9M
- Earning Date
- UXIN 06-12-2025
- PRTA 08-07-2025
- Dividend Yield
- UXIN N/A
- PRTA N/A
- EPS Growth
- UXIN N/A
- PRTA N/A
- EPS
- UXIN 0.94
- PRTA N/A
- Revenue
- UXIN $300,239,165.00
- PRTA $137,935,000.00
- Revenue This Year
- UXIN N/A
- PRTA N/A
- Revenue Next Year
- UXIN N/A
- PRTA $119.20
- P/E Ratio
- UXIN $3.41
- PRTA N/A
- Revenue Growth
- UXIN 58.48
- PRTA 54.55
- 52 Week Low
- UXIN $1.41
- PRTA $4.32
- 52 Week High
- UXIN $7.84
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- UXIN 43.76
- PRTA 53.00
- Support Level
- UXIN $3.75
- PRTA $5.64
- Resistance Level
- UXIN $3.97
- PRTA $6.36
- Average True Range (ATR)
- UXIN 0.37
- PRTA 0.38
- MACD
- UXIN -0.00
- PRTA 0.25
- Stochastic Oscillator
- UXIN 15.65
- PRTA 87.23
About UXIN Uxin Limited ADS
Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).